Kromek Share Discussion Threads

[aqc888] 09/9/2021 10:49

14th September is the before mentioned exhibition at excel. Where the theme of the show is relevant to the detector. I wouldn’t want to sell out now with details that could be released then. Remember there will be buyers of the machine there - if they have any details it would be a good time to release them.

[b00mb0y] 09/9/2021 10:41

Could well do, strategicinvestor. Its the same old, same old. Promises, promises.

[strategicinvestor2] 09/9/2021 10:33

Could drift back to 15p due to impatience for news later that financial year ?? Thought ?

[dexter1612] 09/9/2021 10:15

Hopefully you can see this. Your a tit. I'll filter you now.

[b00mb0y] 09/9/2021 09:30

Come on, rampers. This stock is teetering on the cliffs. I’ve got big steaks in this. Do your job and get this share price going north.

[b00mb0y] 09/9/2021 08:17

@dixter
Are you gambling on the coulds?'

It's the stock market, that's what you do.
Yeah, your right, you were better when filtered.

So you unfiltered me. You obviously find me interesting then. Haha. If not, then just filter me again. Bye.

[aqc888] 09/9/2021 07:58

Quepassa, so what’s your interest in Kromek? I’m guessing you’ve lost a chunk of money in Kromek from the early days and a little bit bitter about it all?

[quepassa] 09/9/2021 07:08

oh I do apologise if you feel my posts are lacking substance.

I hope this one of mine from earlier this year on 6th April 2021 (post 4244) helps rectify the situation. Perhaps you weren't on the board at the time or missed it.





"Using figures from Equity Development (7/10/20), this is Kromek's seven year performance.

Rounded by me to nearest half-million.


1. TURNOVER FIGURES.

2014 £6m
2015 £8m
2016 £8.5m
2017 £9m
2018 £12m
2019 £14.5m
2020 £13m


These TURNOVER figures include PRODUCT and OTHER.

I assume (but am not certain) that OTHER includes/means grants and research funding. For example, in 2016 OTHER was £3m. In 2019 OTHER was £2.5m



TURNOVER total for last 7 years is £71 million.


2. PROFIT BEFORE TAX - ADJUSTED

2014 -£4.5m LOSS
2015 -£3m LOSS
2016 -£4m LOSS
2017 -£4m LOSS
2018 -£2.5m LOSS
2019 -£1.5m LOSS
2020 -£4m LOSS


LOSS BEFORE TAX (ADJUSTED) for last seven years is £23.5 million.


3. EQUITY RAISING SINCE IPO

30/7/15 £11million
25/1/17 £21million
12/2/19 £21million
12/2/21 £13million


They had raised £53m by end 2020. And the new 2021 Placing, brings total to £66m.

A great deal of shareholder dilution.


4.

SUMMARY. SEVEN YEARS

TURNOVER £71m
LOSS £23.5m
EQUITY RAISINGS £53m (+ another £13m in 2021)



Where does so much money go?

With so many positive messages and so many sure-fire guaranteed, copper-bottomed, game-changer, cutting-edge, state-of-the-art and innovative whizzbang new product initiatives, mostly announced to piggy-back off the latest global scare (nuclear detection, airport security, medical imaging, ventilators ,covid), why does this company still make such resolute losses?


The Easter weekend marked the 7th. anniversary of the infamous 4/4/14 RNS announcement of the seven year up to $159million CZT-based detection modules contract in China.



You see, if you add together ALL Kromek's TURNOVER for the last seven years, the whole lot doesn't come anywhere close to what that ONE SINGLE CONTRACT was meant to bring in.

ALL IMO. DYOR.
QP

"



ALL IMO. DYOR.
QP

[aqc888] 09/9/2021 06:53

Need to remember that in China, Australia etc they are still closing down areas when a covid case is identified. Big market. Very different approach to U.K. we should remember U.K. is taking an approach which is very different to a lot of other countries.

Also we need to remember that variants seem to be evading the vaccines and that should a new worse variant pop up the machine will be of huge importance.

There will also be niche areas where there detector would be very useful. When a niche area is identified and sold to globally sales will boom. If elderly are found to be vulnerable for example. At £20k per machine it’s not out of the range of many institutions buying just to reassure staff, students, residents etc.

Then there are the sales to governments who are interested in testing cases in the community. Remember the ONS study at the moment is visiting over 100,000 households monthly paying each resident of that house £25 each for swab samples at a cost of well over £10m per month. So governments are still very interested in monitoring the virus in the community. I can envisage many uses for the machine.

People also forget future products Kromek scientists can develop. Something which would be well priced into the share price on a Nasdaq listing

[dexter1612] 09/9/2021 06:32

'Are you gambling on the coulds?'It's the stock market, that's what you do.Yeah, your right, you were better when filtered.

[ark87] 09/9/2021 00:43

The longer the wait the less optimistic i am the covid detector will generate significant revenues. If it was knocking it out the park surely they would have it out by now considering the world is crying out for something like this.

[aqc888] 08/9/2021 21:27

Boomboy, we’re both overly exposed to Kromek, i think I remember you saying Kromek were 40% of your portfolio. It’s 10% of mine currently and showing a 25% profit. I’d generally think it’s unwise holding so much in a single AIM company. I’m nervously keeping a close eye on Kromek. Disappointed there was no news today on the trial results. Hopefully some details will be released when they show the detector at the Excel exhibition on the 14th next week.... I suspect the CFO was taking a more reserved under promise over deliver approach when giving his timescale of the end of this financial year for detector results. The CEO just seems a disaster causing false hope constantly. Partly why there is such little confidence in Kromek

[b00mb0y] 08/9/2021 21:07

Retirementfund. Is that all you have to say to answer QuePassa’s detailed blog. Log off pal and go back o bed.

[aqc888] 08/9/2021 21:07

It’s pretty normal quepassa for a company developing a lot of new class leading products not to be profitable. The various products they have developed so far will produce a small profit this financial year. Meanwhile on the side they have developed the biological pathogen detector whilst generating that small profit for the year. Here are some other facts...

Order book covers 75 per cent of revenue estimates for 2021/22 financial year.

£20m worth of nuclear sector revenue in active procurement that could be delivered this year.

Estimated turnover of £15m this year.

House broker Cenkos Securities expects gross margins to rise from 48 to 52 per cent, so with the benefit of a relatively fixed cost base last year’s Covid-19 impacted cash loss of £1.7m is forecast to produce a small adjusted cash profit.

Hill at Equity Development values the annual global market for the biological threat detection devices at £500m.

[b00mb0y] 08/9/2021 21:02

@dixter. Thought you had filtered me.
“ Just a sample. So what part of that is not informed and relevant information that could provide significant tailwind to the company that we are invested in?”
“Could” is a little bit like “if”. hmmm
Are you gambling on the “could’s”, dixter?

[b00mb0y] 08/9/2021 20:56

AQC. Your post 5092, along with nearly all your posts have been interesting to read and inline with my views in the main. However, this is now becoming a bit ridiculous (and I don’t mean you or your posts) to say the least. There’s no need here to reiterate over everything but all positive posts about KMK on this site have become nothing but massive ramping. In all those posts (ramping posts) there is the word “if” and they’re always massive IF’s. This is not meant as a jibe to you but to all the pathetic ramping that’s being written here.
As I said earlier, I’m gambling on the massive IF’s.
Good luck!

[retirementfund] 08/9/2021 20:52

What is the brokers forecast for next year. I suspect this is more important than the last 7 years. All in my opinion.

[quepassa] 08/9/2021 20:35

oh I do apologise if you feel my posts are lacking substance.

I hope this one of mine from earlier this year on 6th April 2021 (post 4244) helps rectify the situation. Perhaps you weren't on the board at the time or missed it.





"Using figures from Equity Development (7/10/20), this is Kromek's seven year performance.

Rounded by me to nearest half-million.


1. TURNOVER FIGURES.

2014 £6m
2015 £8m
2016 £8.5m
2017 £9m
2018 £12m
2019 £14.5m
2020 £13m


These TURNOVER figures include PRODUCT and OTHER.

I assume (but am not certain) that OTHER includes/means grants and research funding. For example, in 2016 OTHER was £3m. In 2019 OTHER was £2.5m



TURNOVER total for last 7 years is £71 million.


2. PROFIT BEFORE TAX - ADJUSTED

2014 -£4.5m LOSS
2015 -£3m LOSS
2016 -£4m LOSS
2017 -£4m LOSS
2018 -£2.5m LOSS
2019 -£1.5m LOSS
2020 -£4m LOSS


LOSS BEFORE TAX (ADJUSTED) for last seven years is £23.5 million.


3. EQUITY RAISING SINCE IPO

30/7/15 £11million
25/1/17 £21million
12/2/19 £21million
12/2/21 £13million


They had raised £53m by end 2020. And the new 2021 Placing, brings total to £66m.

A great deal of shareholder dilution.


4.

SUMMARY. SEVEN YEARS

TURNOVER £71m
LOSS £23.5m
EQUITY RAISINGS £53m (+ another £13m in 2021)



Where does so much money go?

With so many positive messages and so many sure-fire guaranteed, copper-bottomed, game-changer, cutting-edge, state-of-the-art and innovative whizzbang new product initiatives, mostly announced to piggy-back off the latest global scare (nuclear detection, airport security, medical imaging, ventilators ,covid), why does this company still make such resolute losses?


The Easter weekend marked the 7th. anniversary of the infamous 4/4/14 RNS announcement of the seven year up to $159million CZT-based detection modules contract in China.



You see, if you add together ALL Kromek's TURNOVER for the last seven years, the whole lot doesn't come anywhere close to what that ONE SINGLE CONTRACT was meant to bring in.

ALL IMO. DYOR.
QP

"



ALL IMO. DYOR.
QP

[dexter1612] 08/9/2021 20:15

Fevered hype?? If you look back at the posts that you are referring to they reference articles or news that's relevant to the field that Kromeks operates.Examples Millions of dollars into US bio detection and early warning.Reports of calls for government to protect schools with bio detection.Just a sample. So what part of that is not informed and relevant information that could provide significant tailwind to the company that we are invested in?It informs other holders on the general sentiment and enviroment that Kromek operates. How they interpret that information is for them. So less of your fevered hype pish. I'm yet to see what if any you and that other boom boy fella offer ,other than glib and idle comments about mismanagement.As many have said, contrary views are welcome and needed for balance. If they have any substance or logic.....I'm still waiting to see any from both of you.

[aqc888] 08/9/2021 19:45

Losing faith? Well any AIM company boomboy is slightly off-piste with higher risks and requires faith. They also come with higher rewards, navigating your way through the limited information is what makes these forums more interesting. I think it’s fair to say the unknowns around Kromek are what is causing the irrational exuberance and fear, with the share price surging and falling every few months. As I always say regarding Kromek, the management seem a little poor. But what we’re all here for is the potential scientific achievements of its scientists in developing the biological pathogen detector, which will be largely patented and years ahead of rivals in an area which is of huge importance to many nations and institutions around the world at the moment (bio-terrorism & pandemic). If Kromek achieves what we’re hoping for it will have a substantial economic moat around its biological pathogen detector. When losing faith you’ve got to remember the track record of Kromeks scientists, which are first class, from their leading medical scanners, leading award winning security x-ray scanners & leading radiation detectors. Kromeks scientists clearly have the ability to produce first class products and if they manage to pull off this biological pathogen detector it’s going to be huge.

[retirementfund] 08/9/2021 17:52

b00mb0y not a chance your the one spouting unresearched tripe. Happy to see how it plays out I am very comfortable with my investment and level of research. All in my opinion

[quepassa] 08/9/2021 17:26

so no news then about the covid sniffer thingamajig.

doesn't surprise me despite all the fevered hype from multiple posters over the last several weeks.

Post 5086 is a bull's-eye.

all imo. dyor.
qp

[b00mb0y] 08/9/2021 17:08

Oh, by the way, retirementfund. What’s your researched opinion on KMK then. Let’s have it please.